Staged anesthesia for cesarean delivery in a parturient with a history of Wilson disease: a case report
This case report describes a successful staged anesthetic strategy for cesarean delivery in a parturient with Wilson disease, cirrhosis, and coagulopathy, which avoided neuraxial and immediate general anesthesia to achieve favorable maternal and neonatal outcomes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Pregnancy is a time of profound physiological change, where the body's fluid balance, blood clotting systems, and organ function shift to support a growing life. For most women, these changes are manageable, but for those with pre-existing liver disease, the stakes are significantly higher. The liver acts as the body's chemical processing plant, filtering toxins, producing proteins, and creating the factors necessary for blood to clot. When this organ is damaged by a genetic condition called Wilson disease, it struggles to handle the extra workload of pregnancy. Wilson disease causes copper to build up in the body, damaging the liver and nervous system over time. If a woman with this condition and advanced liver scarring needs to give birth, the medical team faces a difficult puzzle: how to perform a surgical delivery without triggering a fatal bleed or exposing the baby to harmful drugs. The choice of anesthesia becomes a high-wire act, balancing the risk of bleeding from a spinal needle against the risks of putting the mother and baby to sleep with general anesthesia.
This story centers on a thirty-four-year-old woman at thirty-five weeks and five days of pregnancy who arrived at the hospital with severe abdominal pain. She had a long history of Wilson disease, which had progressed to cirrhosis, or severe scarring of the liver, and had caused her spleen to enlarge significantly. Her blood tests revealed a dangerous combination of problems: her platelet count, which helps blood clot, was low at 58 times ten to the ninth power per liter, and her blood took longer than normal to clot. Because her platelet count was so low and her liver function was worsening, the medical team decided that a standard spinal or epidural anesthetic was too risky. These common techniques involve inserting a needle into the spine, which could cause a dangerous bleed in a patient with such poor clotting. However, putting her to sleep completely before the baby was born would mean the baby would be exposed to strong anesthetic drugs, potentially affecting their breathing and alertness at birth.
The team devised a unique, two-step strategy to navigate this dilemma. Before the baby was delivered, they avoided putting the mother to sleep entirely. Instead, they used a combination of a sedative drug called esketamine and a local anesthetic injected directly into the layers of her abdominal wall. This approach kept the mother awake enough to breathe on her own while numbing the surgical site, allowing the surgeons to make the incision and open the abdomen without the baby being exposed to heavy anesthesia. Once the uterus was exposed and the baby was ready to be delivered, the team switched to a full general anesthetic. They placed a mask over the mother's airway, administered drugs to induce sleep and muscle relaxation, and delivered the baby. The infant, a girl weighing 2580 grams, was born healthy with perfect scores for her breathing and heart rate at one, five, and ten minutes after birth.
The surgery revealed about 500 milliliters of pale-yellow fluid in the abdomen, a sign of the liver disease, but the procedure itself was completed without major complications. The mother received blood products to support her low platelet count and anemia, and her vital signs remained stable throughout. In the days following the surgery, she experienced some bloody drainage from tubes placed in her abdomen, which is common after such procedures, but the amount gradually decreased. Her liver function tests showed a temporary rise in bilirubin, a yellow pigment that builds up when the liver is stressed, but she remained clinically stable. After eight days in the hospital, both the mother and the baby were discharged together, with the mother advised to seek specialized care for her liver condition.
This case report highlights a specific, individualized approach to a very rare and complex medical situation. The authors emphasize that while this staged method worked well for this single patient, it is not a proven solution for everyone. The success relied on a precise balance of drugs, careful monitoring, and a seamless transition between two different types of anesthesia. The medical team noted that the mother required a significant amount of blood products after the surgery, suggesting that the bleeding risk was real and required active management. They also pointed out that the long-term outcome for the mother's liver health could not be fully determined from this single event, as follow-up data was limited. The report serves as a detailed example of how medical teams can adapt standard procedures to protect both mother and child when the usual options are too dangerous, offering a glimpse into the careful, step-by-step decision-making required in high-risk obstetrics.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.